Total value in 2019: $778.57M

Company Partner Amount ($M) Details Date

October - $17M

Evotec SE (Hamburg, Germany) Aeovian Pharmaceuticals Inc. (San Francisco) N/A Evotec reached a milestone as part of its 2017 partnership with Aeovian Pharmaceuticals triggering an undisclosed payment to Evotec 10/7/19
Ionis Pharmaceuticals Inc. (Carlsbad, Calif.) Bayer AG (Leverkusen, Germany) $10.00 Ionis received a $10M milestone payment related to Bayer's continuation decision to advance IONIS-FXI-LRx following positive clinical results 10/10/19
PGI Drug Discovery LLC (Paramus, N.J.) Sunovion Pharmaceuticals Inc. (Marlborough, Mass.) N/A PGI Drug Discovery received undisclosed milestone payments from Sunovion Pharmaceuticals associated with the advancement of SEP-378614 and SEP-380135 into clinical testing 10/3/19
Rigel Pharmaceuticals Inc. (South San Francisco) Aclaris Therapeutics Inc. (Wayne, Pa.) $4.00 Rigel received a $4M development milestone payment related to a JAK inhibitor licensed by Aclaris Therapeutics 10/3/19
Sosei Group Corp. (Tokyo) Genentech Inc. $3.00 Genentech to select a new G protein-coupled receptor, or GPCR, disease target, which triggered a $3M payment to Sosei Heptares 10/10/19
Sutro Biopharma Inc. (South San Francisco) Merck KGaA (Darmstadt, Germany) N/A Sutro Biopharma achieved a milestone under its collaboration and license deal with Merck KGaA and is entitled to a milestone payment linked to the designation by Merck of an undisclosed bispecific antibody-drug conjugate (ADC) as a clinical candidate with approval to advance to IND-enabling studies 10/10/19

No Comments